Chad J Kolean - Net Worth and Insider Trading

Chad J Kolean Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Chad J Kolean owns 1 companies in total, including Cellectar Biosciences Inc (CLRB) .

Click here to see the complete history of Chad J Kolean’s form 4 insider trades.

Insider Ownership Summary of Chad J Kolean

Ticker Comapny Transaction Date Type of Owner
CLRB Cellectar Biosciences Inc 2022-02-24 Chief Financial Officer

Chad J Kolean Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Chad J Kolean Ownership Network

Ownership Network List of Chad J Kolean

No Data

Ownership Network Relation of Chad J Kolean

Insider Network Chart

Chad J Kolean Owned Company Details

What does Cellectar Biosciences Inc do?

Who are the key executives at Cellectar Biosciences Inc?

Chad J Kolean is the Chief Financial Officer of Cellectar Biosciences Inc. Other key executives at Cellectar Biosciences Inc include Senior Vice President & Medical Andrei Shustov , Chief Commercial Officer Darrell Shane Lea , and director & President and CEO James V Caruso .

Cellectar Biosciences Inc (CLRB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cellectar Biosciences Inc (CLRB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cellectar Biosciences Inc (CLRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cellectar Biosciences Inc (CLRB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cellectar Biosciences Inc Insider Transactions

No Available Data

Chad J Kolean Mailing Address

Above is the net worth, insider trading, and ownership report for Chad J Kolean. You might contact Chad J Kolean via mailing address: C/o Cellectar Biosciences, Inc., 3301 Agriculture Drive, Madison Wi 53716.

Discussions on Chad J Kolean

No discussions yet.